Chronic Obstructive Pulmonary Disease in Lung Cancer Patients: Prevalence, Underdiagnosis, and Clinical Characterization

Respiration

Volumn 95, Issue 6, 2018, Pages 414-421

  Mouronte Roibás, Cecilia ^a,b   Leiro Fernández, Virginia ^a,b   Ruano Raviña, Alberto ^d   Ramos Hernández, Cristina ^a,b   Abal Arca, José ^c   Parente Lamelas, Isaura ^c   Botana Rial, Maribel ^a,b   Priegue Carrera, Ana ^a,b   Fernández Villar, Alberto ^a,b  

^a EOXI de Vigo   (Spain)

^b NeumoVigoI+i Research Group   (Spain)

^c Instituto de Investigación Biomédica Ourense Vigo Pontevedra   (Spain)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Chronic obstructive pulmonary disease; Lung cancer; Prevalence; Underdiagnosis

Indexed keywords

ADVANCED CANCER; AGED; ARTICLE; BODY MASS; CANCER STAGING; CANCER SURVIVAL; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HISTOPATHOLOGY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SEX DIFFERENCE; SEX RATIO; SURVIVAL RATE; UNIVARIATE ANALYSIS; ADENOCARCINOMA; CLINICAL TRIAL; COMPLICATION; LUNG TUMOR; MIDDLE AGED; SPAIN; SQUAMOUS CELL CARCINOMA; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; PREVALENCE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPAIN;

EID: 85044543428     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000487243     Document Type: Article

References (56)

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136:E359-E386.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. Alberg AJ, Brock MV, Ford JG, Samet JM, Spivack SD: Epidemiology of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143(5 suppl):e1S-e29S.
4. De Angelis R, Sant M, Coleman MP, Fran-cisci S, Baili P, Pierannunzio D, et al: Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 - a population-based study. Lancet Oncol 2014; 15: 23-34.
5. Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, et al: Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery. Arch Bronconeumol 2012; 48: 247-257.
6. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr: Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992; 339: 1268-1278.
7. Fletcher C, Peto R, Tinker C, Speizer FE: The Natural History of Chronic Bronchitis and Emphysema. New York, Oxford University Press, 1976.
8. El-Zein RA, Young RP, Hopkins RJ, Etzel CJ: Genetic predisposition to chronic obstructive pulmonary disease and/or lung cancer: important considerations when evaluating risk. Cancer Prev Res (Phila) 2012; 5: 522-527.
9. Durham AL, Adcock IM: The relationship between COPD and lung cancer. Lung Cancer 2015; 90: 121-127.
10. Wang Z: Association between chronic obstructive pulmonary disease and lung cancer: the missing link. Chin Med J (Engl) 2013; 126: 154-165.
11. Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD: COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J 2009; 34: 380-386.
12. Henschke CI, Yip R, Boffetta P, Markowitz S, Miller A, Hanaoka T, et al: CT screening for lung cancer: importance of emphysema for never smokers and smokers. Lung Cancer 2015; 88: 42-47.
13. Abal Arca J, Parente Lamelas I, Almazán Ortega R, Blanco Pérez J, Toubes Navarro ME, Marcos Velázquez P: Lung cancer and COPD: a common combination. Arch Bronconeumol 2009; 45: 502-507.
14. Smith BM, Pinto L, Ezer N, Sverzellati N, Muro S, Schwartzman K: Emphysema detected on computed tomography and risk of lung cancer: a systematic review and meta-analysis. Lung Cancer 2012; 77: 58-63.
15. Sekine Y, Katsura H, Koh E, Hiroshima K, Fujisawa T: Early detection of COPD is important for lung cancer surveillance. Eur Respir J 2012; 39: 1230-1240.
16. Mannino DM, Aguayo SM, Petty TL, Redd SC: Low lung function and incident lung cancer in the United States: data from the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med 2003; 163: 1475-1480.
17. De-Torres JP, Wilson DO, Sanchez-Salcedo P, Weissfeld JL, Berto J, Campo A, et al: Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score. Am J Respir Crit Care Med 2015; 191: 285-291.
18. De Torres JP, Marín JM, Casanova C, Cote C, Carrizo S, Cordoba-Lanus E, et al: Lung cancer in patients with chronic obstructive pulmonary disease-incidence and predicting factors. Am J Respir Crit Care Med 2011; 184: 913-919.
19. Rodríguez-Roisin R, Soriano JB: Chronic obstructive pulmonary disease with lung cancer and/or cardiovascular disease. Proc Am Thorac Soc 2008; 5: 842-847.
20. Li Y, Swensen SJ, Karabekmez LG, Marks RS, Stoddard SM, Jiang R, et al: Effect of emphysema on lung cancer risk in smokers: a computed tomography-based assessment. Cancer Prev Res (Phila) 2011; 4: 43-50.
21. De Torres JP, Bastarrika G, Wisnivesky JP, Alcaide AB, Campo A, Seijo LM, et al: Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest 2007; 132: 1932-1938.
22. De-Torres JP, Marín JM, Casanova C, Pinto-Plata V, Divo M, Cote C, et al: Identification of COPD patients at high risk for lung cancer mortality using the COPD-LUCSS-DLCO. Chest 2016; 149: 936-942.
23. Leiro-Fernández V, Botana-Rial M, Tilve-Gómez A, Represas-Represas C, Pallarés-Sanmartín A, Fernández-Villar A: Effectiveness of a protocolized system to alert pulmonologists of lung cancer radiological suspi-cion. Clin Transl Oncol 2014; 16: 64-68.
24. Rami-Porta R, Crowley JJ, Goldstraw P: The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg 2009; 15: 4-9.
25. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-365.
26. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
27. Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, et al: Spanish guideline for COPD (GesEPOC). Update 2014. Arch Bronconeumol 2014; 50 (suppl 1): 1-16.
28. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N: Development and first validation of the COPD Assessment Test. Eur Respir J 2009; 34: 648-654.
29. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-1012.
30. Soler-Cataluña JJ, Martínez-García MA, Sánchez LS, Tordera MP, Sánchez PR: Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients. Respir Med 2009; 103: 692-699.
31. García-Río F, Calle M, Burgos F, Casan P, Del Campo F, Galdiz JB, et al: Spirometry. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Arch Bronconeumol 2013; 49: 388-401.
32. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al: Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
33. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al: Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012; 40: 1324-1343.
34. Qin J, Li G, Zhou J: Characteristics of elderly patients with COPD and newly diagnosed lung cancer, and factors associated with treatment decision. Int J Chron Obstruct Pulmon Dis 2016; 11: 1515-1520.
35. Zhang J, Zhou J, Lin X, Shen WD, Liu JC, Wu GG: Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population. Respirology 2013; 18: 297-302.
36. Sekine Y, Fujisawa T, Suzuki K, Tsutatani S, Kubota K, Ikegami H, et al: Detection of chronic obstructive pulmonary disease in community-based annual lung cancer screening: Chiba Chronic Obstructive Pulmonary Disease Lung Cancer Screening Study Group. Respirology 2014; 19: 98-104.
37. Arnedillo Muñoz A: The underdiagnosis of chronic obstructive pulmonary disease in women. Another pending task? Arch Bronconeumol 2013; 49: 221-222.
38. Mohan A, Mohan C, Pathak AK, Pandey RM, Guleria R: Impact of chronic obstructive pulmonary disease on respiratory status and quality of life in newly diagnosed patients with lung cancer. Respirology 2007; 12: 240-247.
39. Huang R, Wei Y, Hung RJ, Liu G, Su L, Zhang R, et al: Associated links among smoking, chronic obstructive pulmonary disease, and small cell lung cancer: a pooled analysis in the International Lung Cancer Consortium. EBioMedicine 2015; 2: 1677-1685.
40. Sanchez-Salcedo P, Berto J, de-Torres JP, Campo A, Alcaide AB, Bastarrika GG, et al: Lung cancer screening: fourteen year experience of the Pamplona Early Detection Program (P-IELCAP). Arch Bronconeumol 2015; 51: 169-176.
41. Torres-Durán M, Ruano-Ravina A, Parente-Lamelas I, Leiro-Fernández V, Abal-Arca J, Montero-Martínez C, et al: Small-cell lung cancer in never smokers: a case-control study in a radon-prone area (Galicia, Spain). Eur Respir J 2014; 44: 994-1001.
42. Montero C, Rosales M, Otero I, Blanco M, Rodríguez G, Peterga S, et al: Lung cancer in the health care area of A Coruña (Spain): incidence, clinical approach and survival (in Spanish). Arch Bronconeumol 2003; 39: 209-216.
43. Leiro-Fernández V, Mouronte-Roibás C, Ramos-Hernández C, Botana-Rial M, González-Piñeiro A, García-Rodríguez E, et al: Changes in clinical presentation and staging of lung cancer over two decades. Arch Bronconeumol 2014; 50: 417-421.
44. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, et al: International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011; 6: 244-285.
45. Janssen-Heijnen MLG, Coebergh JWW: The changing epidemiology of lung cancer in Europe. Lung Cancer 2003; 41: 245-258.
46. Smith BM, Schwartzman K, Kovacina B, Taylor J, Kasymjanova G, Brandao G, et al: Lung cancer histologies associated with emphysema on computed tomography. Lung Cancer 2012; 76: 61-66.
47. Decramer M, Janssens W: Chronic obstructive pulmonary disease and comorbidities. Lancet Respir Med 2013; 1: 73-83.
48. Islam KMM, Jiang X, Anggondowati T, Lin G, Ganti AK: Comorbidity and survival in lung cancer patients. Cancer Epidemiol Biomarkers Prev 2015; 24: 1079-1085.
49. Grose D, Morrison DS, Devereux G, Jones R, Sharma D, Selby C, et al: Comorbidities in lung cancer: prevalence, severity and links with socioeconomic status and treatment. Postgrad Med J 2014; 90: 305-310.
50. Iachina M, Jakobsen E, Møller H, Lüchtenborg M, Mellemgaard A, Krasnik M, Green A: The effect of different comorbidities on survival of non-small cells lung cancer patients. Lung 2015; 193: 291-297.
51. Luo J, Solimini NL, Elledge SJ: Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 2009; 136: 823-837.
52. Negrini S, Gorgoulis VG, Halazonetis TD: Genomic instability - an evolving hallmark of cancer. Nat Rev Mol Cell Biol 2010; 11: 220-228.
53. Volgelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med 2017; 195: 557-582.
54. Seijo LM, Zulueta JJ: Understanding the links between lung cancer, COPD, and emphysema: a key to more effective treatment and screening. Oncology (Williston Park) 2017; 31: 93-102.
55. Rooney C, Sethi T: The epithelial cell and lung cancer: the link between chronic obstructive pulmonary disease and lung cancer. Respiration 2011; 81: 89-104.
56. Adcock IM, Caramori G, Barnes PJ: Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration 2011; 81: 265-284.